Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse

Multiple myeloma remains an incurable disease with the usual disease course requiring induction therapy, autologous stem cell transplantation for eligible patients, and long-term maintenance. Risk stratification tools and cytogenetic alterations help inform individualized therapeutic choices for pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Parva, Kloock, Colin, Comenzo, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954856/
https://www.ncbi.nlm.nih.gov/pubmed/36826140
http://dx.doi.org/10.3390/curroncol30020179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954856/
https://www.ncbi.nlm.nih.gov/pubmed/36826140
http://dx.doi.org/10.3390/curroncol30020179

Ejemplares similares